Acknowledgement to Cochrane Library.
1 Practising evidence-based respiratory medicine.
1.2 Diagnostic strategies.
1.2.1 Presenting symptoms.
1.2.2 Lung function testing.
1.2.3 Chest radiographic and CT patterns.
1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach.
1.2.5 Screening for lung cancer.
1.3 Therapeutics: general issues.
1.3.1 Adherence and self-management.
1.3.2 Corticosteroid-induced osteoporosis.
1.3.3 Helping people to stop smoking.
2.1 Acute exacerbations.
2.2 Chronic therapy: beta-agonists – short-acting, long-acting beta2-agonists.
2.3 Inhaled corticosteroids in the treatment of asthma.
2.5 Asthma education.
.2.6 Non-pharmacological and complementary interventions to manage asthma.
2.7 Difficult asthma.
2.8 Novel therapies in asthma: long-acting beta2-agonists/inhaled corticosteroids.
3 Chronic obstructive pulmonary disease.
3.1 Chronic obstructive pulmonary disease – acute exacerbations.
3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy.
3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease.
3.4 Combination of inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease.
3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease.
3.6 Lung volume reduction.
4.1 Bronchitis and sinusitis.
4.2 Community-acquired pneumonia.
4.3 Pulmonary tuberculosis.
4.4 Influenza: vaccination and treatment.
4.6 Adult cystic fibrosis.
4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis.
5 Respiratory failure/sleep disordered breathing.
5.1 Respiratory rehabilitation.
5.2 Non-invasive ventilation in acute respiratory failure.
5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?
5.4 The treatment of the obstructive sleep apnoea–hypopnoea syndrome.
5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease.
6 Diffuse lung disease / pleural disease / thromboembolism.
6.1 Diffuse lung disease.
6.1.1 The treatment of cryptogenic fibrosing alveolitis.
6.1.2 Evidence-based approach to treatment of sarcoidosis.
6.1.3 Hypersensitivity pneumonitis.
6.2 Pleural disease.
6.3 Therapy of pulmonary thromboembolism: an evidence-based approach.
6.4 Pulmonary hypertension.
- First major evidence-based text in adult respiratory medicine
- Comprehensive, authoritative summary of the best treatments for the major respiratory diseases
- Compiled by specialists from the Cochrane Airways Management Group
- Easy-to-use format, with key clinical implications summarised in each chapter
- Kept up-to-date online at: www.evidbasedrespiratorymed.com